{
    "nctId": "NCT05767931",
    "briefTitle": "Development of Multi-specific Antibodies Based on Immune Microenvironment of Breast Cancer",
    "officialTitle": "Development of Multi-specific Antibodies Based on Immune Microenvironment of Breast Cancer",
    "overallStatus": "NOT_YET_RECRUITING",
    "conditions": "Invasive Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 60,
    "primaryOutcomeMeasure": "antitumor rate of multi-specific antibody in patient-derived organoids and PDX model",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Women between 18 and 70 years old\uff1b\n2. Primary lesion \\>2cm on imaging examination, or suspected axillary lymph node metastasis on imaging examination\uff1b\n3. Previous not received preoperative radiotherapy, chemotherapy, endocrine therapy, immunotherapy, or other anticancer treatments\uff1b\n4. Subjects signed informed consent\uff1b\n\nExclusion Criteria:\n\n1. A history of prior or concomitant malignancies;\n2. Advanced stage breast cancer (stage IV)\uff1b\n3. Suspected or confirmed lesion was surgically removed\uff1b\n4. Patients were accompanied by severe organic diseases such as heart and cerebral disease, and liver and kidney disease.\uff1b",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}